[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Rampa et al., 2001 - Google Patents

Acetylcholinesterase inhibitors: SAR and kinetic studies on ω-[N-methyl-N-(3-alkylcarbamoyloxyphenyl) methyl] aminoalkoxyaryl derivatives

Rampa et al., 2001

Document ID
5418909982118973944
Author
Rampa A
Piazzi L
Belluti F
Gobbi S
Bisi A
Bartolini M
Andrisano V
Cavrini V
Cavalli A
Recanatini M
Valenti P
Publication year
Publication venue
Journal of Medicinal Chemistry

External Links

Snippet

In this work, we further investigated a class of carbamic cholinesterase inhibitors introduced in a previous paper (Rampa et al. J. Med. Chem. 1998, 41, 3976). Some new ω-[N-methyl-N- (3-alkylcarbamoyloxyphenyl) methyl] aminoalkoxyaryl analogues were designed …
Continue reading at pubs.acs.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom

Similar Documents

Publication Publication Date Title
Rampa et al. Acetylcholinesterase inhibitors: SAR and kinetic studies on ω-[N-methyl-N-(3-alkylcarbamoyloxyphenyl) methyl] aminoalkoxyaryl derivatives
Rampa et al. Acetylcholinesterase inhibitors: synthesis and structure− activity relationships of ω-[N-Methyl-N-(3-alkylcarbamoyloxyphenyl)-methyl] aminoalkoxyheteroaryl derivatives
Belluti et al. Cholinesterase inhibitors: Xanthostigmine derivatives blocking the acetylcholinesterase-induced β-amyloid aggregation
Bolognesi et al. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues
Hroch et al. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer’s disease treatment
Montanari et al. Fatty acid amide hydrolase (FAAH), acetylcholinesterase (AChE), and butyrylcholinesterase (BuChE): networked targets for the development of carbamates as potential anti-Alzheimer’s disease agents
Sonmez et al. Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors
Binda et al. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs
Zhu et al. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
Wang et al. Dual functional cholinesterase and MAO inhibitors for the treatment of Alzheimer’s disease: synthesis, pharmacological analysis and molecular modeling of homoisoflavonoid derivatives
Li et al. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer’s disease
Saeedi et al. Design and synthesis of selective acetylcholinesterase inhibitors: arylisoxazole‐phenylpiperazine derivatives
Yu et al. Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1, 2-oxazines
Bagheri et al. Synthesis and anticholinergic activity of 4‐hydroxycoumarin derivatives containing substituted benzyl‐1, 2, 3‐triazole moiety
Saeedi et al. Design and synthesis of novel arylisoxazole‐chromenone carboxamides: Investigation of biological activities associated with Alzheimer's disease
Pisani et al. Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium‐like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors
Andersson et al. Divergent structure–activity relationships of structurally similar acetylcholinesterase inhibitors
Estrada-Valencia et al. New flavonoid–N, N-dibenzyl (N-methyl) amine hybrids: Multi-target-directed agents for Alzheimer´ s disease endowed with neurogenic properties
Bolognesi et al. Bis (7)‐tacrine derivatives as multitarget‐directed ligands: focus on anticholinesterase and antiamyloid activities
Zhou et al. Simple analogues of natural product chelerythrine: Discovery of a novel anticholinesterase 2-phenylisoquinolin-2-ium scaffold with excellent potency against acetylcholinesterase
Modh et al. Design, Synthesis, Biological Evaluation, and Molecular Modeling of Coumarin–P iperazine Derivatives as Acetylcholinesterase Inhibitors
Lemke et al. Chromenones as multineurotargeting inhibitors of human enzymes
Mohammadi‐Khanaposhtani et al. New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes
Coban et al. 1 H-benzimidazole derivatives as butyrylcholinesterase inhibitors: synthesis and molecular modeling studies
Andrade-Jorge et al. Isoindolines/isoindoline-1, 3-diones as AChE inhibitors against Alzheimer’s disease, evaluated by an improved ultra-micro assay